A 58-year-old man from rural Maharashtra presents to a primary health centre with acute onset chest pain radiating to the left arm for 2 hours. He is diaphoretic and anxious. Blood pressure is 145/92 mmHg, heart rate 102/min. His 12-lead ECG shows ST elevation of 3 mm in leads II, III, and aVF with reciprocal ST depression in leads I and aVL. Troponin I is pending. The nearest PCI-capable centre is 180 km away (approximately 3 hours by road). What is the most appropriate immediate management?

Explanation

## Clinical Scenario Analysis This is an **inferior wall STEMI** (ST elevation in II, III, aVF with reciprocal changes) presenting within the 12-hour window in a patient at a non-PCI-capable facility with a 3-hour transfer time. ## Reperfusion Strategy Decision **Key Point:** When PCI-capable centre is >120 minutes away and symptom onset <12 hours, **fibrinolytic therapy (thrombolysis)** is the preferred reperfusion strategy per ACC/AHA and Indian guidelines. **High-Yield:** The "door-to-balloon time" for PCI should be ≤90 minutes from first medical contact. If this cannot be achieved, fibrinolysis should be initiated immediately at the presenting facility, followed by transfer ("fibrinolysis-facilitated PCI" strategy). ## Management Algorithm ```mermaid flowchart TD A[STEMI confirmed on ECG]:::outcome --> B{PCI-capable centre<br/>within 120 min?}:::decision B -->|Yes| C[Primary PCI]:::action B -->|No| D{Symptom onset<br/>< 12 hours?}:::decision D -->|Yes| E[Fibrinolysis immediately]:::action D -->|No| F[Medical management]:::action E --> G[Aspirin + P2Y12 inhibitor<br/>+ Streptokinase IV]:::action G --> H[Transfer for rescue PCI<br/>if needed]:::action C --> I[Reperfusion achieved]:::outcome H --> I ``` ## Dual Antiplatelet Therapy in This Case | Agent | Dose | Timing | Notes | |-------|------|--------|-------| | Aspirin | 325 mg | Immediate | Loading dose, then 75 mg daily | | Clopidogrel | 600 mg | Immediate | Loading dose for fibrinolysis; ticagrelor 180 mg is preferred for PCI | | Streptokinase | 1.5 million units IV | Over 60 min | Fibrinolytic of choice in India due to cost; infliximab contraindications must be excluded | **Clinical Pearl:** Streptokinase is a non-selective fibrinolytic with good efficacy in STEMI and is the most affordable option in resource-limited settings. Clopidogrel is preferred over ticagrelor in the fibrinolysis pathway because ticagrelor's rapid onset is optimized for PCI, not fibrinolysis. ## Why This Patient Needs Fibrinolysis 1. **Distance barrier:** 180 km (3 hours) exceeds the 120-minute guideline threshold for primary PCI. 2. **Time-critical presentation:** 2 hours from onset — well within the 12-hour window for fibrinolytic efficacy. 3. **Inferior STEMI:** Lower mortality risk than anterior STEMI, making fibrinolysis a safe option. 4. **Resource availability:** Streptokinase is immediately available at PHC level in India. **Warning:** Do NOT delay reperfusion by transferring a patient 3 hours away when fibrinolysis can be given immediately. "Time is muscle" — every 30-minute delay in reperfusion increases 1-year mortality by ~7.5%. [cite:Harrison 21e Ch 297]